Private Equity 24 Hours

Last updated: June 5, 2026, 5:30 PM ET

Fundraising & Capital Commitments TJC set a $8.5bn target for its seventh Resolute Fund, aiming to deepen exposure to North‑American mid‑market platforms, while Norvestor closed its €2bn flagship just three months after launch, exceeding the prior vehicle by €500m. In parallel, CPP enlarged its forward‑flow line with Affirm to $1.7bn for a 24‑month term and retained the option to scale to $2.2bn, a move that underpins roughly $8bn of consumer‑loan originations. The trio of commitments underscores a broad‑based appetite for long‑duration capital among private‑equity sponsors as they chase steady cash‑flow assets.

Strategic Acquisitions & Carve‑Outs Mill Point moved to buy Total Safety Supplies, adding the industrial‑products distributor to its portfolio and expanding its foothold in the U.S. safety market. Meanwhile, Mutares secured a sale of Walor Precision Turning to Reed Capital, completing the latest automotive‑component carve‑out from the Walor Group. In Europe, Consilium took a minority stake in Twin Pack, giving the packaging‑systems maker access to growth capital without ceding control, while Allianz GI edged toward a $467m deal for UOB Asset Management, outbidding rivals KKR and Amundi. These transactions illustrate sponsors’ focus on niche, high‑margin businesses that can be scaled through operational expertise.

Public‑Market Exits & Deal Reversals Advent and ADIA raised $2.43bn through Innio’s Nasdaq debut, where the gas‑engine producer surged 23% on first‑day trading, highlighting investor enthusiasm for clean‑energy hardware. A month later, Blackstone‑backed Liftoff opened at $4.18bn after its shares rose roughly 9%, delivering a fresh public‑market outlet for ad‑tech assets. Conversely, Apollo withdrew its $2bn bid for Bodycote amid rising fraud concerns in M&A, signalling heightened diligence scrutiny. At the same time, Oxford Bio Medica signalled openness to bidders after rebuffing EQT, keeping the FTSE‑250 gene‑therapy specialist in play for a potential take‑private.

Regulatory & Market Sentiment Florida’s SBA council debated benchmark relevance for its $219bn pension, reflecting growing unease over private‑equity performance metrics in a low‑interest environment. Across the Atlantic, legal‑AI investors poured billions into plaintiff platforms while defense‑side solutions remain under‑funded, a gap that could reshape future fund allocations. Together, these developments point to a sector that is both expanding its capital base and recalibrating risk assessments amid evolving market dynamics.